Association of Polygenic Liability for Autism With Face-Sensitive Cortical Responses From Infancy

TY - JOUR

T1 - Association of Polygenic Liability for Autism With Face-Sensitive Cortical Responses From Infancy

AU - Gui, Anna

AU - Meaburn, Emma L.

AU - Tye, Charlotte

AU - Charman, Tony

AU - Johnson, Mark H.

AU - Jones, Emily

N1 - Funding Information: Funding/Support: The genetic data collection and generation and manuscript preparation were funded by grant 642996 from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie actions, grant ES/R009368/1 from the Economic and Social Research Council to Drs Gui and Jones, and by grant 511504 from the Simons Foundation Autism Research Initiative (SFARI) Pilot Award to Drs Jones and Meaburn. The experimental and behavioral data collection for all phases of the British Autism Study of Infant Siblings (BASIS) was funded by grants G0701484 and MR/ K021389/1 from the Medical Research Council Programme, the BASIS funding consortium led by Autistica (http://www.basisnetwork.org). The electroencephalography and behavioral data collection used in this publication received partial funding from the Innovative Medicines Initiative Joint Funding Information: Undertaking under grant agreement 115300 for the European Autism Interventions—A Multicentre Study for Developing New Medications (EU-AIMS) project, which receives resources from the European Union’s Seventh Framework Programme (FP7/2007-2013) and the European Federation of Pharmaceutical Industries and Associations companies (EFPIA), and by the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement 777394 for the project AIMS-2-TRIALS, which receives support from the European Union’s Horizon 2020 research and innovation program, the European Federation of Pharmaceutical Industries and Associations companies’ in-kind contributions, Autism Speaks, Autistica, and the Simons Foundation for Autism Research Initiative. Funding Information: Skłodowska-Curie and Economic and Social Research Council during the conduct of the study. Dr Meaburn received the Simons Foundation Autism Research Initiative (SFARI) Pilot Award during the conduct of the study. Dr Charman reports grants from Medical Research Council, European Union Horizon 2020, and Innovative Medicines Initiative during the conduct of the study; as well as personal fees from F. Hoffmann-La Roche and Servier and royalties from Sage Publications and Guilford Publications outside the submitted work. Dr Jones reports grants from Medical Research Council, Simons Foundation, Economic and Social Research Council, European Union Horizon 2020, and Innovative Medicines Initiative during the conduct of the study. No other disclosures were reported.

PY - 2021/9

Y1 - 2021/9

UR - http://www.scopus.com/inward/record.url?scp=85107872740&partnerID=8YFLogxK

U2 - 10.1001/jamapediatrics.2021.1338

DO - 10.1001/jamapediatrics.2021.1338

M3 - Letter

SN - 2168-6203

VL - 175

SP - 968

EP - 970

JO - JAMA Pediatrics

JF - JAMA Pediatrics

IS - 9

ER -